XTANT MEDICAL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $9.60 per share for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2016-08-10
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2014-03-31 was $1.47, a 49.13% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2013-03-31 was $2.89, a 75.15% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2012-03-31 was $1.65.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2013 was $1.76, a 18.89% decline from fiscal 2012.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2012 was $2.17, a 10.33% decline from fiscal 2011.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2011 was $2.42.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | $9.60 10-Q · filed 2016-08-10 | ||||
| 2015-06-30 | $12.86 10-Q · filed 2016-08-10 | ||||
| 2014-06-30 | $18.30 10-Q · filed 2014-08-14 | ||||
| 2014-03-31 | $1.47 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $1.76 10-K · filed 2014-03-27 | ||||
| 2013-09-30 | $1.78 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $17.90 10-Q · filed 2014-08-14 | $1.79 10-Q · filed 2013-08-13 | |||
| 2013-03-31 | $2.89 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $2.17 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $2.01 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | $1.92 10-Q · filed 2013-08-13 | ||||
| 2012-03-31 | $1.65 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $2.42 10-K · filed 2013-03-27 | ||||
| 2011-09-30 | $2.94 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | $3.27 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |